Advanced oxidation protein products decrease the expression of calcium transport channels in small intestinal epithelium via the p44/42 MAPK signaling pathway

European Journal of Cell Biology

Volumn 94, Issue 5, 2015, Pages 190-203

  Wu, Peiqun ^a   Xie, Fang ^a   Xue, Minmin ^a   Xu, Xiaoping ^a   He, Shuying ^a   Lin, Minyi ^a   Bai, Lan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Advanced oxidation protein products; Calcium; Calcium transport channels; Intestinal epithelium; Mitogen activated protein kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM ION; CHLORIDE; HORMONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARATHYROID HORMONE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; S100 CALCIUM BINDING PROTEIN G; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN; STRESS ACTIVATED PROTEIN KINASE; VANILLOID RECEPTOR 6; ADVANCED OXIDATION PROTEIN PRODUCTS; BUTADIENES; CALCIUM CHANNELS; ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; U 0126;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL MEMBRANE; CHLORIDE BLOOD LEVEL; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; DOWN REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTRACELLULAR SIGNALING; MALE; NONHUMAN; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMALL INTESTINE; SODIUM BLOOD LEVEL; VITAMIN BLOOD LEVEL; ANIMALS; ANTAGONISTS AND INHIBITORS; BLOOD; CACO-2 CELLS; DOWN-REGULATION; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; METABOLISM; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

ADVANCED OXIDATION PROTEIN PRODUCTS; ANIMALS; BUTADIENES; CACO-2 CELLS; CALCIUM; CALCIUM CHANNELS; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PARATHYROID HORMONE; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84973226427     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2015.02.002     Document Type: Article

References (46)

1. Agrawal M., Arora S., Li J., Rahmani R., Sun L., Steinlauf A.F., Mechanick J.I., Zaidi M. Bone, inflammation, and inflammatory bowel disease. Curr. Osteoporos. Rep. 2011, 9:251-257.
2. Alagozlu H., Gorgul A., Bilgihan A., Tuncer C., Unal S. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Clin. Res. Hepatol. Gastroenterol. 2012.
3. Almenier H.A., Al M.H., Maher M.M., Al G.S. Oxidative stress and inflammatory bowel disease. Front. Biosci. (Elite Ed.) 2012, 4:1335-1344.
4. Baskol M., Baskol G., Kocer D., Ozbakir O., Yucesoy M. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis. J. Clin. Gastroenterol. 2008, 42:687-691.
5. Bianchi M.L. Inflammatory bowel diseases, celiac disease, and bone. Arch. Biochem. Biophys. 2010, 503:54-65.
6. Bogeski I., Kappl R., Kummerow C., Gulaboski R., Hoth M., Niemeyer B.A. Redox regulation of calcium ion channels: chemical and physiological aspects. Cell Calcium 2011, 50:407-423.
7. Card T., West J., Hubbard R., Logan R.F. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004, 53:251-255.
8. Chang D., Wang F., Zhao Y.S., Pan H.Z. Evaluation of oxidative stress in colorectal cancer patients. Biomed. Environ. Sci. 2008, 21:286-289.
9. Chen S.X., Song T., Zhou S.H., Liu Y.H., Wu S.J., Liu L.Y. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Eur. J. Pharmacol. 2008, 584:368-375.
10. El-Najjar N., Chatila M., Moukadem H., Vuorela H., Ocker M., Gandesiri M. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 2010, 15:183-195.
11. Genant H.K., Mall J.C., Wagonfeld J.B., Horst J.V., Lanzi L.H. Skeletal demineralization and growth retardation in inflammatory bowel disease. Invest. Radiol. 1976, 11:541-549.
12. Guo Z.J., Niu H.X., Hou F.F., Zhang L., Fu N., Nagai R., Lu X., Chen B.H., Shan Y.X., Tian J.W., Nagaraj R.H., Xie D., Zhang X. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid. Redox Signal. 2008, 10:1699-1712.
13. Hoenderop J.G., Nilius B., Bindels R.J. Calcium absorption across epithelia. Physiol. Rev. 2005, 85:373-422.
14. Jantarajit W., Thongon N., Pandaranandaka J., Teerapornpuntakit J., Krishnamra N., Charoenphandhu N. Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by the phosphoinositide 3-kinase pathway. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E372-E384.
15. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
16. Kalousova M., Skrha J., Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 2002, 51:597-604.
17. Kellett G.L. Alternative perspective on intestinal calcium absorption: proposed complementary actions of Ca(v)1.3 and TRPV6. Nutr. Rev. 2011, 69:347-370.
18. Kosova F., Cetin B., Akinci M., Aslan S., Ari Z., Sepici A., Altan N., Cetin A. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer. Ann. Surg. Oncol. 2007, 14:2616-2620.
19. Krzystek-Korpacka M., Neubauer K., Berdowska I., Boehm D., Zielinski B., Petryszyn P., Terlecki G., Paradowski L., Gamian A. Enhanced formation of advanced oxidation protein products in IBD. Inflamm. Bowel Dis. 2008, 14:794-802.
20. Li H.Y., Hou F.F., Zhang X., Chen P.Y., Liu S.X., Feng J.X., Liu Z.Q., Shan Y.X., Wang G.B., Zhou Z.M., Tian J.W., Xie D. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J. Am. Soc. Nephrol. 2007, 18:528-538.
21. Lieben L., Carmeliet G. The involvement of TRP channels in bone homeostasis. Front. Endocrinol. (Lausanne) 2012, 3:99.
22. Lin C.L., Moniz C., Chambers T.J., Chow J.W. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996, 111:1263-1271.
23. Liu S.X., Hou F.F., Guo Z.J., Nagai R., Zhang W.R., Liu Z.Q., Zhou Z.M., Zhou M., Xie D., Wang G.B., Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1156-1162.
24. Martin-Gallan P., Carrascosa A., Gussinye M., Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free. Radic. Biol. Med. 2003, 34:1563-1574.
25. Moschen A.R., Kaser A., Enrich B., Ludwiczek O., Gabriel M., Obrist P., Wolf A.M., Tilg H. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005, 54:479-487.
26. Nakkrasae L.I., Thongon N., Thongbunchoo J., Krishnamra N., Charoenphandhu N. Transepithelial calcium transport in prolactin-exposed intestine-like Caco-2 monolayer after combinatorial knockdown of TRPV5, TRPV6 and Ca(v)1.3. J. Physiol. Sci. 2010, 60:9-17.
27. Omi N., Ezawa I. Animal models for bone and joint disease. Low calcium diet-induced rat model of osteoporosis. Clin. Calcium 2011, 21:173-180.
28. Plotnikov A., Zehorai E., Procaccia S., Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta 2011, 1813:1619-1633.
29. Sebekova K., Klenovicsova K., Ferenczova J., Hedvig J., Podracka L., Heidland A. Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency. J. Renal Nutr. 2012, 22:143-148.
30. Skvarilova M., Bulava A., Stejskal D., Adamovska S., Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed. Pap.: Med. Fac. Univ. Palacky Olomouc Czech Repub. 2005, 149:83-87.
31. Waring P. Redox active calcium ion channels and cell death. Arch. Biochem. Biophys. 2005, 434:33-42.
32. Wei X.F., Zhou Q.G., Hou F.F., Liu B.Y., Liang M. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am. J. Physiol.: Renal Physiol. 2009, 296:F427-F437.
33. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49:1304-1313.
34. Witko-Sarsat V., Friedlander M., Nguyen K.T., Capeillere-Blandin C., Nguyen A.T., Canteloup S., Dayer J.M., Jungers P., Drueke T., Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J. Immunol. 1998, 161:2524-2532.
35. Wu C.Y., Hsieh H.L., Jou M.J., Yang C.M. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J. Neurochem. 2004, 90:1477-1488.
36. Xiao Y., Cui J., Shi Y.H., Sun J., Wang Z.P., Le G.W. Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice. Nutrition 2010, 26:1188-1194.
37. Xie F., Sun S., Xu A., Zheng S., Xue M., Wu P., Zeng J.H., Bai L. Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway. Cell Death Dis. 2014, 5:e1006.
38. Yang S.H., Sharrocks A.D., Whitmarsh A.J. MAP kinase signalling cascades and transcriptional regulation. Gene 2013, 513:1-13.
39. Zheng S., Zhong Z.M., Qin S., Chen G.X., Wu Q., Zeng J.H., Ye W.B., Li W., Yuan K., Yao L., Chen J.T. Advanced oxidation protein products induce inflammatory response in fibroblast-like synoviocytes through NADPH oxidase-dependent activation of NF-kappaB. Cell. Physiol. Biochem. 2013, 32:972-985.
40. Zhong Z.M., Bai L., Chen J.T. Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-kappaB pathway. Cell. Physiol. Biochem. 2009, 24:105-114.
41. Zhou L.L., Cao W., Xie C., Tian J., Zhou Z., Zhou Q., Zhu P., Li A., Liu Y., Miyata T., Hou F.F., Nie J. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. Kidney Int. 2012, 82:759-770.
42. Zhou L.L., Hou F.F., Wang G.B., Yang F., Xie D., Wang Y.P., Tian J.W. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int. 2009, 76:1148-1160.
43. Zhou Q.G., Zhou M., Lou A.J., Xie D., Hou F.F. Advanced oxidation protein products induce inflammatory response and insulin resistance in cultured adipocytes via induction of endoplasmic reticulum stress. Cell. Physiol. Biochem. 2010, 26:775-786.
44. Zill H., Gunther R., Erbersdobler H.F., Folsch U.R., Faist V. RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. Biochem. Biophys. Res. Commun. 2001, 288:1108-1111.
45. Zupan J., Komadina R., Marc J. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. J. Biomed. Sci. 2012, 19:28.
46. Zuwala-Jagiello J., Pazgan-Simon M., Simon K., Warwas M. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochim. Pol. 2011, 58:59-65.